|
| |
| | | 53362 | | 23.01.1996 | | Pfizer AG | | 02.11.2005 | | | | | | | | | | | 01.08. | | | | 01.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Cabaser 1 mg | Tabletten | Tablets (Cabergoline 1 mg) | N04BC06 | CI | | 02 | Cabaser 2 mg | Tabletten | Tablets (Cabergoline 2 mg) | N04BC06 | CI | | 03 | Cabaser 4 mg | Tabletten | Tablets () | N04BC06 | CI |
|
|
|
